Skip to main content
OpenTrials
Completed

NCT Number: NCT02213562

Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

The aim of this study is to investigate the efficacy and dose-dependency of chrysanthemum flower oil in suppressing serum uric acid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperuricemia Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

30 year–60 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Hiroshima University

Hiroshima, 734-8551, Japan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Serum uric acid 6.8-8.9 mg/dL

Exclusion criteria

  • Taking anti-hyperuricemic drugs
  • History of gouty attack
  • Taking drugs or functional food that may affect serum uric acid level
  • Hypertention, hyperlipidemia, or diabetes millitus
  • Participation in any clinical trial within 90 days of the commencement of the trial
  • Renal or hepatic dysfunction
  • Heart disease
  • History of severe disease and/or major surgery

Treatment and study plan

200 mg of chrysanthemum flower oil

Dietary Supplement

300 mg of chrysanthemum flower oil

Dietary Supplement

400 mg of chrysanthemum flower oil

Dietary Supplement

Primary outcomes

  1. Change in serum uric acid from baseline

    Time frame: Every 4 weeks (Overall 8 weeks)

  2. Change in uric acid clearance from baseline

    Time frame: Every 4 weeks (Overall 8 weeks)

Sponsors and collaborators

Lead sponsor

Hiroshima University

Other

Collaborators

  • Kaneka Corporation

Registry information

Official study title

A Randomized, Double-blind, Parallel Group Study to Evaluate the Effect of Chrysanthemum Flower Oil and Its Dose-dependency in Subjects With Hyperuricemia

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Aug 11, 2014
Registry last updated
Aug 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.